nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMD1—medulla oblongata—meningioma	0.0112	0.0574	CbGeAlD
Bortezomib—PSMD1—spinal cord—meningioma	0.00999	0.0511	CbGeAlD
Bortezomib—PSMD2—medulla oblongata—meningioma	0.00992	0.0508	CbGeAlD
Bortezomib—PSMA1—cerebellum—meningioma	0.00943	0.0483	CbGeAlD
Bortezomib—PSMD2—spinal cord—meningioma	0.00885	0.0453	CbGeAlD
Bortezomib—PSMB5—medulla oblongata—meningioma	0.00871	0.0446	CbGeAlD
Bortezomib—PSMD1—cerebellum—meningioma	0.00792	0.0406	CbGeAlD
Bortezomib—PSMB5—spinal cord—meningioma	0.00777	0.0398	CbGeAlD
Bortezomib—PSMA1—brain—meningioma	0.00766	0.0392	CbGeAlD
Bortezomib—PSMB1—medulla oblongata—meningioma	0.00762	0.039	CbGeAlD
Bortezomib—PSMB2—medulla oblongata—meningioma	0.00743	0.038	CbGeAlD
Bortezomib—PSMD2—cerebellum—meningioma	0.00702	0.0359	CbGeAlD
Bortezomib—PSMB1—spinal cord—meningioma	0.00679	0.0348	CbGeAlD
Bortezomib—PSMB2—spinal cord—meningioma	0.00663	0.0339	CbGeAlD
Bortezomib—SLC31A1—medulla oblongata—meningioma	0.00643	0.0329	CbGeAlD
Bortezomib—PSMD1—brain—meningioma	0.00643	0.0329	CbGeAlD
Bortezomib—PSMB5—cerebellum—meningioma	0.00616	0.0315	CbGeAlD
Bortezomib—SLC31A1—spinal cord—meningioma	0.00574	0.0294	CbGeAlD
Bortezomib—PSMD2—brain—meningioma	0.0057	0.0292	CbGeAlD
Bortezomib—PSMB8—brain—meningioma	0.00566	0.029	CbGeAlD
Bortezomib—PSMB1—cerebellum—meningioma	0.00538	0.0276	CbGeAlD
Bortezomib—PSMB2—cerebellum—meningioma	0.00525	0.0269	CbGeAlD
Bortezomib—PSMB5—brain—meningioma	0.005	0.0256	CbGeAlD
Bortezomib—SLC31A1—cerebellum—meningioma	0.00455	0.0233	CbGeAlD
Bortezomib—PSMB1—brain—meningioma	0.00437	0.0224	CbGeAlD
Bortezomib—PSMB2—brain—meningioma	0.00427	0.0218	CbGeAlD
Bortezomib—SLC31A1—brain—meningioma	0.0037	0.0189	CbGeAlD
Bortezomib—CYP2D6—brainstem—meningioma	0.00226	0.0116	CbGeAlD
Bortezomib—PTGS1—spinal cord—meningioma	0.00171	0.00876	CbGeAlD
Bortezomib—CYP2C8—brain—meningioma	0.00136	0.00696	CbGeAlD
Bortezomib—CYP1A1—brain—meningioma	0.00126	0.00643	CbGeAlD
Bortezomib—CYP2D6—cerebellum—meningioma	0.00112	0.00571	CbGeAlD
Bortezomib—PTGS1—brain—meningioma	0.0011	0.00564	CbGeAlD
Bortezomib—CYP2D6—brain—meningioma	0.000906	0.00464	CbGeAlD
Bortezomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000657	0.000816	CbGpPWpGaD
Bortezomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000657	0.000816	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SMO—meningioma	0.000655	0.000815	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SMO—meningioma	0.000652	0.000811	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SMO—meningioma	0.000649	0.000807	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000648	0.000805	CbGpPWpGaD
Bortezomib—PSMA1—Signaling by WNT in cancer—AKT1—meningioma	0.00063	0.000782	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PGR—meningioma	0.000628	0.000781	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—ERBB2—meningioma	0.000628	0.00078	CbGpPWpGaD
Bortezomib—PSMD1—Signaling by WNT in cancer—AKT1—meningioma	0.000627	0.000779	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PGR—meningioma	0.000625	0.000777	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—ERBB2—meningioma	0.000625	0.000777	CbGpPWpGaD
Bortezomib—PSMD2—Signaling by WNT in cancer—AKT1—meningioma	0.000624	0.000775	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PGR—meningioma	0.000622	0.000774	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—ERBB2—meningioma	0.000622	0.000773	CbGpPWpGaD
Bortezomib—PSMA1—Disease—HES1—meningioma	0.000614	0.000762	CbGpPWpGaD
Bortezomib—PSMD1—Disease—HES1—meningioma	0.000611	0.000759	CbGpPWpGaD
Bortezomib—PSMD2—Disease—HES1—meningioma	0.000608	0.000755	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism of RNA—AKT1—meningioma	0.000597	0.000742	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism of RNA—AKT1—meningioma	0.000594	0.000739	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism of RNA—AKT1—meningioma	0.000592	0.000735	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TSHB—meningioma	0.000584	0.000726	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TSHB—meningioma	0.000584	0.000726	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TSHB—meningioma	0.000584	0.000726	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—AKT1—meningioma	0.00058	0.000721	CbGpPWpGaD
Bortezomib—PSMB2—B Cell Activation—AKT1—meningioma	0.00058	0.000721	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—AKT1—meningioma	0.00058	0.000721	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TSHB—meningioma	0.000576	0.000716	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—AKT1—meningioma	0.000572	0.000711	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—PDGFB—meningioma	0.000568	0.000706	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ALAD—meningioma	0.000567	0.000704	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—PDGFB—meningioma	0.000566	0.000703	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—PDGFB—meningioma	0.000563	0.0007	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—PTEN—meningioma	0.000536	0.000666	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—PTEN—meningioma	0.000533	0.000662	CbGpPWpGaD
Bortezomib—PSMB1—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000531	0.000659	CbGpPWpGaD
Bortezomib—PSMB5—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000531	0.000659	CbGpPWpGaD
Bortezomib—PSMB2—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000531	0.000659	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—PTEN—meningioma	0.00053	0.000659	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism of mRNA—AKT1—meningioma	0.000529	0.000657	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism of mRNA—AKT1—meningioma	0.000529	0.000657	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism of mRNA—AKT1—meningioma	0.000529	0.000657	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PDGFB—meningioma	0.000525	0.000652	CbGpPWpGaD
Bortezomib—PSMB8—TCF dependent signaling in response to WNT—AKT1—meningioma	0.000523	0.00065	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PDGFB—meningioma	0.000522	0.000649	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism of mRNA—AKT1—meningioma	0.000521	0.000648	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PDGFB—meningioma	0.00052	0.000646	CbGpPWpGaD
Bortezomib—PSMA1—Signaling by Wnt—AKT1—meningioma	0.000519	0.000645	CbGpPWpGaD
Bortezomib—PSMD1—Signaling by Wnt—AKT1—meningioma	0.000516	0.000642	CbGpPWpGaD
Bortezomib—PSMD2—Signaling by Wnt—AKT1—meningioma	0.000514	0.000639	CbGpPWpGaD
Bortezomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000514	0.000638	CbGpPWpGaD
Bortezomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000514	0.000638	CbGpPWpGaD
Bortezomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000514	0.000638	CbGpPWpGaD
Bortezomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000507	0.000629	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SMO—meningioma	0.000497	0.000617	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SMO—meningioma	0.000497	0.000617	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SMO—meningioma	0.000497	0.000617	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SMO—meningioma	0.00049	0.000609	CbGpPWpGaD
Bortezomib—PSMB5—Signaling by WNT in cancer—AKT1—meningioma	0.000477	0.000593	CbGpPWpGaD
Bortezomib—PSMB1—Signaling by WNT in cancer—AKT1—meningioma	0.000477	0.000593	CbGpPWpGaD
Bortezomib—PSMB2—Signaling by WNT in cancer—AKT1—meningioma	0.000477	0.000593	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PGR—meningioma	0.000476	0.000592	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PGR—meningioma	0.000476	0.000592	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PGR—meningioma	0.000476	0.000592	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—ERBB2—meningioma	0.000476	0.000591	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—ERBB2—meningioma	0.000476	0.000591	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—ERBB2—meningioma	0.000476	0.000591	CbGpPWpGaD
Bortezomib—PSMB8—Signaling by WNT in cancer—AKT1—meningioma	0.00047	0.000585	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PGR—meningioma	0.00047	0.000584	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—ERBB2—meningioma	0.000469	0.000583	CbGpPWpGaD
Bortezomib—PSMB5—Disease—HES1—meningioma	0.000465	0.000578	CbGpPWpGaD
Bortezomib—PSMB1—Disease—HES1—meningioma	0.000465	0.000578	CbGpPWpGaD
Bortezomib—PSMB2—Disease—HES1—meningioma	0.000465	0.000578	CbGpPWpGaD
Bortezomib—PSMB8—Disease—HES1—meningioma	0.000458	0.00057	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism of RNA—AKT1—meningioma	0.000453	0.000562	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism of RNA—AKT1—meningioma	0.000453	0.000562	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism of RNA—AKT1—meningioma	0.000453	0.000562	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism of RNA—AKT1—meningioma	0.000446	0.000554	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—PDGFB—meningioma	0.000431	0.000535	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—PDGFB—meningioma	0.000431	0.000535	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—PDGFB—meningioma	0.000431	0.000535	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—HES1—meningioma	0.00043	0.000534	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—HES1—meningioma	0.000428	0.000531	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—HES1—meningioma	0.000426	0.000529	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—PDGFB—meningioma	0.000425	0.000528	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—PTEN—meningioma	0.000406	0.000504	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—PTEN—meningioma	0.000406	0.000504	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—PTEN—meningioma	0.000406	0.000504	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—PTEN—meningioma	0.0004	0.000497	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALAD—meningioma	0.000399	0.000496	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle—TP53—meningioma	0.000399	0.000496	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PDGFB—meningioma	0.000398	0.000494	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PDGFB—meningioma	0.000398	0.000494	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PDGFB—meningioma	0.000398	0.000494	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle—TP53—meningioma	0.000397	0.000493	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle—TP53—meningioma	0.000395	0.000491	CbGpPWpGaD
Bortezomib—PSMB5—Signaling by Wnt—AKT1—meningioma	0.000393	0.000489	CbGpPWpGaD
Bortezomib—PSMB1—Signaling by Wnt—AKT1—meningioma	0.000393	0.000489	CbGpPWpGaD
Bortezomib—PSMB2—Signaling by Wnt—AKT1—meningioma	0.000393	0.000489	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PDGFB—meningioma	0.000392	0.000487	CbGpPWpGaD
Bortezomib—PSMB8—Signaling by Wnt—AKT1—meningioma	0.000388	0.000482	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—ERBB2—meningioma	0.000381	0.000473	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—ERBB2—meningioma	0.000379	0.000471	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ERBB2—meningioma	0.000377	0.000469	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PDGFB—meningioma	0.000367	0.000457	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALAD—meningioma	0.000366	0.000455	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PDGFB—meningioma	0.000366	0.000454	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—TSHB—meningioma	0.000365	0.000454	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PDGFB—meningioma	0.000364	0.000452	CbGpPWpGaD
Bortezomib—PSMA1—Disease—ERBB2—meningioma	0.000352	0.000437	CbGpPWpGaD
Bortezomib—PSMD1—Disease—ERBB2—meningioma	0.00035	0.000435	CbGpPWpGaD
Bortezomib—PSMD2—Disease—ERBB2—meningioma	0.000348	0.000433	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALAD—meningioma	0.000327	0.000406	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—HES1—meningioma	0.000326	0.000405	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—HES1—meningioma	0.000326	0.000405	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—HES1—meningioma	0.000326	0.000405	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—PTEN—meningioma	0.000325	0.000404	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—PTEN—meningioma	0.000323	0.000402	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—PTEN—meningioma	0.000322	0.0004	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—HES1—meningioma	0.000321	0.000399	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—AKT1—meningioma	0.000309	0.000384	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—AKT1—meningioma	0.000307	0.000382	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—AKT1—meningioma	0.000306	0.00038	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—TP53—meningioma	0.000302	0.000376	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—TP53—meningioma	0.000302	0.000376	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle—TP53—meningioma	0.000302	0.000376	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALAD—meningioma	0.000301	0.000374	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PTEN—meningioma	0.0003	0.000373	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PTEN—meningioma	0.000298	0.000371	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—TP53—meningioma	0.000298	0.00037	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALAD—meningioma	0.000298	0.00037	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PTEN—meningioma	0.000297	0.000369	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ERBB2—meningioma	0.000289	0.000359	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ERBB2—meningioma	0.000289	0.000359	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ERBB2—meningioma	0.000289	0.000359	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ERBB2—meningioma	0.000285	0.000354	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PDGFB—meningioma	0.000278	0.000346	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PDGFB—meningioma	0.000278	0.000346	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PDGFB—meningioma	0.000278	0.000346	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PDGFB—meningioma	0.000275	0.000341	CbGpPWpGaD
Bortezomib—PSMB2—Disease—ERBB2—meningioma	0.000267	0.000331	CbGpPWpGaD
Bortezomib—PSMB5—Disease—ERBB2—meningioma	0.000267	0.000331	CbGpPWpGaD
Bortezomib—PSMB1—Disease—ERBB2—meningioma	0.000267	0.000331	CbGpPWpGaD
Bortezomib—PSMB8—Disease—ERBB2—meningioma	0.000263	0.000327	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—TSHB—meningioma	0.000257	0.00032	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALAD—meningioma	0.000255	0.000316	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PTEN—meningioma	0.000251	0.000312	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PTEN—meningioma	0.00025	0.000311	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PTEN—meningioma	0.000249	0.000309	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—ERBB2—meningioma	0.000246	0.000306	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—PTEN—meningioma	0.000246	0.000306	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—PTEN—meningioma	0.000246	0.000306	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—PTEN—meningioma	0.000246	0.000306	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—ERBB2—meningioma	0.000245	0.000305	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—ERBB2—meningioma	0.000244	0.000303	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—PTEN—meningioma	0.000243	0.000302	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—TSHB—meningioma	0.000236	0.000293	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—AKT1—meningioma	0.000234	0.000291	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—AKT1—meningioma	0.000234	0.000291	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—AKT1—meningioma	0.000234	0.000291	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—AKT1—meningioma	0.000231	0.000287	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PTEN—meningioma	0.000227	0.000282	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PTEN—meningioma	0.000227	0.000282	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PTEN—meningioma	0.000227	0.000282	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PTEN—meningioma	0.000224	0.000278	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000223	0.000278	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TSHB—meningioma	0.000211	0.000262	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PTEN—meningioma	0.00021	0.000261	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PTEN—meningioma	0.000209	0.00026	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PTEN—meningioma	0.000208	0.000259	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALAD—meningioma	0.000197	0.000244	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TSHB—meningioma	0.000194	0.000241	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TSHB—meningioma	0.000192	0.000239	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTEN—meningioma	0.00019	0.000237	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTEN—meningioma	0.00019	0.000237	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTEN—meningioma	0.00019	0.000237	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTEN—meningioma	0.000188	0.000233	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—AKT1—meningioma	0.000187	0.000233	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—ERBB2—meningioma	0.000187	0.000232	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—ERBB2—meningioma	0.000187	0.000232	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—ERBB2—meningioma	0.000187	0.000232	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—AKT1—meningioma	0.000186	0.000232	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—AKT1—meningioma	0.000186	0.000231	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—AKT1—meningioma	0.000185	0.00023	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—AKT1—meningioma	0.000185	0.00023	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—AKT1—meningioma	0.000184	0.000229	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ERBB2—meningioma	0.000184	0.000229	CbGpPWpGaD
Bortezomib—PSMA1—Disease—AKT1—meningioma	0.000173	0.000215	CbGpPWpGaD
Bortezomib—PSMD1—Disease—AKT1—meningioma	0.000172	0.000214	CbGpPWpGaD
Bortezomib—PSMD2—Disease—AKT1—meningioma	0.000171	0.000213	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TSHB—meningioma	0.000164	0.000204	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PTEN—meningioma	0.000159	0.000198	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PTEN—meningioma	0.000159	0.000198	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PTEN—meningioma	0.000159	0.000198	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000157	0.000196	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PTEN—meningioma	0.000157	0.000195	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—AKT1—meningioma	0.000145	0.00018	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000144	0.000179	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—AKT1—meningioma	0.000144	0.000179	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—AKT1—meningioma	0.000143	0.000178	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TP53—meningioma	0.000143	0.000178	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TP53—meningioma	0.000143	0.000177	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TP53—meningioma	0.000142	0.000176	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—AKT1—meningioma	0.000142	0.000176	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—AKT1—meningioma	0.000142	0.000176	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—AKT1—meningioma	0.000142	0.000176	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—AKT1—meningioma	0.000141	0.000175	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—AKT1—meningioma	0.000141	0.000175	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—AKT1—meningioma	0.000141	0.000175	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—AKT1—meningioma	0.00014	0.000174	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—AKT1—meningioma	0.000139	0.000173	CbGpPWpGaD
Bortezomib—PSMB2—Disease—AKT1—meningioma	0.000131	0.000163	CbGpPWpGaD
Bortezomib—PSMB5—Disease—AKT1—meningioma	0.000131	0.000163	CbGpPWpGaD
Bortezomib—PSMB1—Disease—AKT1—meningioma	0.000131	0.000163	CbGpPWpGaD
Bortezomib—PSMB8—Disease—AKT1—meningioma	0.000129	0.00016	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000129	0.00016	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TSHB—meningioma	0.000127	0.000157	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AKT1—meningioma	0.000121	0.00015	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AKT1—meningioma	0.00012	0.00015	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AKT1—meningioma	0.00012	0.000149	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000117	0.000146	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AKT1—meningioma	0.00011	0.000136	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AKT1—meningioma	0.00011	0.000136	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AKT1—meningioma	0.00011	0.000136	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TP53—meningioma	0.000109	0.000135	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TP53—meningioma	0.000109	0.000135	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TP53—meningioma	0.000109	0.000135	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AKT1—meningioma	0.000108	0.000134	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TP53—meningioma	0.000107	0.000133	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.0001	0.000125	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTEN—meningioma	9.95e-05	0.000124	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AKT1—meningioma	9.17e-05	0.000114	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AKT1—meningioma	9.17e-05	0.000114	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AKT1—meningioma	9.17e-05	0.000114	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AKT1—meningioma	9.04e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTEN—meningioma	7.01e-05	8.71e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTEN—meningioma	6.43e-05	7.99e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTEN—meningioma	5.74e-05	7.13e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AKT1—meningioma	5.73e-05	7.13e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTEN—meningioma	5.28e-05	6.56e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTEN—meningioma	5.23e-05	6.5e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTEN—meningioma	4.47e-05	5.56e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AKT1—meningioma	4.04e-05	5.02e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AKT1—meningioma	3.7e-05	4.6e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTEN—meningioma	3.45e-05	4.29e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AKT1—meningioma	3.31e-05	4.11e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AKT1—meningioma	3.04e-05	3.78e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AKT1—meningioma	3.01e-05	3.75e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AKT1—meningioma	2.58e-05	3.2e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AKT1—meningioma	1.99e-05	2.47e-05	CbGpPWpGaD
